BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, November 25, 2024
Breaking News: Healing a health divide (that’s long overdue)
See today's BioWorld Science
Home
» Dual inhibition of RET and YES1 could be option in advanced lung cancer
To read the full story,
subscribe
or
sign in
.
Cancer
Dual inhibition of RET and YES1 could be option in advanced lung cancer
Jan. 11, 2024
No Comments
Lung cancer has benefited from the development of targeted therapies for EGFR, MET and ALK...
BioWorld Science
Cancer
